Olema Pharmaceuticals, Inc. — All Filings
525 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001959173-25-007866 | Dec 19, 2025 | — |
| 144 | — | 0001959173-25-007854 | Dec 19, 2025 | — |
| S-3ASR | S-3ASR | 0001193125-25-316125 | Dec 11, 2025 | — |
| 4 | — | 0001579397-25-000007 | Dec 9, 2025 | Dec 8, 2025 |
| 4 | — | 0001579397-25-000005 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | — | 0001162157-25-000005 | Nov 25, 2025 | Nov 21, 2025 |
| 8-K | 8-K | 0001193125-25-288343 | Nov 19, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-288287 | Nov 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-286206 | Nov 18, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-286466 | Nov 18, 2025 | — |
| S-3MEF | S-3MEF | 0001193125-25-286716 | Nov 18, 2025 | — |
| 8-K | 8-K | 0001193125-25-273228 | Nov 10, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-273236 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-243765 | Oct 20, 2025 | Oct 18, 2025 |
| 4 | — | 0001831410-25-000004 | Sep 18, 2025 | Sep 16, 2025 |
| 144 | — | 0001959173-25-006106 | Sep 18, 2025 | — |
| 144 | — | 0001959173-25-006056 | Sep 16, 2025 | — |
| 8-K | 8-K | 0001750284-25-000007 | Sep 2, 2025 | — |
| 8-K | 8-K | 0000950170-25-106545 | Aug 11, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106565 | Aug 11, 2025 | Jun 30, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0000921895-25-001761 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017240 | Jun 13, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0000950170-25-086256 | Jun 13, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-017232 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017233 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017234 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017235 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017236 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017237 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017238 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017239 | Jun 13, 2025 | Jun 11, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-071958 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001970 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-002374 | May 15, 2025 | — |
| SCHEDULE 13D/A | — | 0000935836-25-000324 | May 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-070291 | May 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-070374 | May 13, 2025 | Mar 31, 2025 |
| 4/A | — | 0000935836-25-000323 | May 13, 2025 | Dec 13, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-059354 | Apr 28, 2025 | — |
| ARS | ARS | 0000950170-25-059364 | Apr 28, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-059348 | Apr 28, 2025 | — |
| 8-K | 8-K | 0000950170-25-041186 | Mar 18, 2025 | — |
| 10-K | 10-K | 0000950170-25-041204 | Mar 18, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-041242 | Mar 18, 2025 | — |
| 8-K | 8-K | 0000950170-25-033073 | Mar 5, 2025 | — |
| 4 | — | 0001415889-25-006147 | Mar 3, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006151 | Mar 3, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006154 | Mar 3, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006158 | Mar 3, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006160 | Mar 3, 2025 | Feb 28, 2025 |